CCM
GBIO

CAAS Capital Management’s Generation Bio GBIO Stock Holding History

CAAS Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,500
Closed -$1.08M – 854
2020
Q3 		$1.08M Hold
3,500
– – 0.03% 334
2020
Q2 		$735K Buy
+3,500
New +$780K 0.02% 289

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAAS Capital Management's GBIO Position: Q4 2020 in Review

CAAS Capital Management sold out of Generation Bio (GBIO) in Q4 2020, closing a stake of 3,500 shares — an estimated $1.08M sold.

CAAS Capital Management first reported a position in GBIO in Q2 2020 and held it in 2 quarters. The position peaked at $1.08M in Q3 2020. 68 funds tracked by Wall St. Rank hold GBIO as of Q4 2020.

  • CAAS Capital Management reported no remaining Generation Bio position as of Q4 2020 after selling out during the quarter.
  • CAAS Capital Management sold 3,500 Generation Bio shares in Q4 2020, an estimated $1.08M.
  • CAAS Capital Management first reported a position in Generation Bio in Q2 2020 and held it in 2 quarters.
  • CAAS Capital Management's Generation Bio position peaked at $1.08M in Q3 2020.
  • 68 funds tracked by Wall St. Rank held Generation Bio as of Q4 2020.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.